Courage C, Oliver KL, Park EJ, Cameron JM, Grabińska KA, Muona M et al (2021) Progressive myoclonus epilepsies-residual unsolved cases have marked genetic heterogeneity including dolichol-dependent protein glycosylation pathway genes. Am J Hum Genet 108(4):722–738. https://doi.org/10.1016/j.ajhg.2021.03.013
Article CAS PubMed PubMed Central Google Scholar
Kim S, Kim MJ, Son H, Hwang S, Kang MK, Chu K et al (2021) Adult-onset rapidly worsening progressive myoclonic epilepsy caused by a novel variant in DHDDS. Ann Clin Transl Neurol 8(12):2319–2326. https://doi.org/10.1002/acn3.51483
Article CAS PubMed PubMed Central Google Scholar
Galosi S, Edani BH, Martinelli S, Hansikova H, Eklund EA, Caputi C et al (2022) De novo DHDDS variants cause a neurodevelopmental and neurodegenerative disorder with myoclonus. Brain 145(1):208–223. https://doi.org/10.1093/brain/awab299
Hamdan FF, Myers CT, Cossette P, Lemay P, Spiegelman D, Laporte AD et al (2017) High rate of recurrent De Novo mutations in Developmental and epileptic encephalopathies. Am J Hum Genet 101(5):664–685. https://doi.org/10.1016/j.ajhg.2017.09.008
Article CAS PubMed PubMed Central Google Scholar
Park EJ, Grabińska KA, Guan Z, Stránecký V, Hartmannová H, Hodaňová K et al (2014) Mutation of Nogo-B receptor, a subunit of cis-prenyltransferase, causes a congenital disorder of glycosylation. Cell Metab 20(3):448–457. https://doi.org/10.1016/j.cmet.2014.06.016
Article CAS PubMed PubMed Central Google Scholar
Wood K, Montgomery T, Devlin AM (2021) DHDDS related epilepsy–report of familial cases and review of the literature. Seizure 91:189–191. https://doi.org/10.1016/j.seizure.2021.06.013
Jiao X, Xue Y, Yang S, Gong P, Niu Y, Wang Q et al (2022) Phenotype of heterozygous variants of dehydrodolichol diphosphate synthase. Dev Med Child Neurol 64(1):125–134. https://doi.org/10.1111/dmcn.14976
Smith L, Malinowski J, Ceulemans S, Peck K, Walton N, Sheidley BR, Lippa N (2023) Genetic testing and counseling for the unexplained epilepsies: an evidence-based practice guideline of the National Society of Genetic Counselors. J Genet Couns 32(2):266–280. https://doi.org/10.1002/jgc4.1646
Minardi R, Licchetta L, Baroni MC, Pippucci T, Stipa C, Mostacci B et al (2020) Whole-exome sequencing in adult patients with developmental and epileptic encephalopathy: it is never too late. Clin Genet 98(5):477–485. https://doi.org/10.1111/cge.13823
Article CAS PubMed Google Scholar
Habela CW, Schatz K, Kelley SA (2024) Genetic testing in Epilepsy: improving outcomes and informing gaps in Research. Epilepsy Currents. https://doi.org/10.1177/15357597241232881
Article PubMed PubMed Central Google Scholar
Sheidley BR, Malinowski J, Bergner AL, Bier L, Gloss DS, Mu W et al (2022) Genetic testing for the epilepsies: a systematic review. Epilepsia 63(2):375–387. https://doi.org/10.1111/epi.17141
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405–424. https://doi.org/10.1038/gim.2015.30
Article PubMed PubMed Central Google Scholar
Malmgren K, Thom M (2012) Hippocampal sclerosis–origins and imaging. Epilepsia 53 Suppl 4:19–33. https://doi.org/10.1111/j.1528-1167.2012.03610.x
Walker MC (2015) Hippocampal sclerosis: causes and Prevention. Semin Neurol 35(3):193–200. https://doi.org/10.1055/s-0035-1552618
Kasperaviciute D, Catarino CB, Matarin M, Leu C, Novy J, Tostevin A et al (2013) Epilepsy, hippocampal sclerosis and febrile seizures linked by common genetic variation around SCN1A. Brain 136(Pt 10):3140–3150. https://doi.org/10.1093/brain/awt233
Comments (0)